Author:
Wang Meng,Han Dong,Yuan Ziming,Hu Hanqing,Zhao Zhixun,Yang Runkun,Jin Yinghu,Zou Chaoxia,Chen Yinggang,Wang Guiyu,Gao Xu,Wang Xishan
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference42 articles.
1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer Statistics, 2017. CA Cancer J. Clin. 67, 7–30 (2017).
2. Marquez-Jurado, S. et al. Mitochondrial levels determine variability in cell death by modulating apoptotic gene expression. Nat. Commun. 9, 389 (2018).
3. Stintzing, S. et al. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial. Lancet Oncol. 17, 1426–1434 (2016).
4. Longley, D. B., Allen, W. L. & Johnston, P. G. Drug resistance, predictive markers and pharmacogenomics in colorectal cancer. Biochim. Biophys. Acta 1766, 184–196 (2006).
5. Galluzzi, L., Bravo-San Pedro, J. M., Levine, B., Green, D. R. & Kroemer, G. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat. Rev. Drug. Discov. 16, 487–511 (2017).
Cited by
146 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献